Relaterat / Kontaktpersoner
Relaterat / Nyheter
Servier and Scandicure enter into agreement to conduct research in the field of metabolic diseases - Servier och Scandicure ingår avtal om forskning inom metabola sjukdomar
Pressmeddelanden • Apr 03, 2018 09:50 CEST
Paris and Gothenburg, 3rd of April, 2018 – Servier, an independent international pharmaceutical company, and Scandicure, a Swedish spin-out of the University of Gothenburg, today announced the establishment of an agreement to exploit Scandicure’s innovation in the field of metabolic disease.